Product Details for: Ocrevus Zunovo

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
920MG/23ML; 23,000UNITS/23ML (40MG/1,000UNITS/ML)
Single-Dose Vial
351(a)
Ocrevus Zunovo
Rx
Proper Name
ocrelizumab and hyaluronidase-ocsq
BLA Number
761371
Applicant
Genentech, Inc.
Original Approval Date
September 13, 2024
Date of First Licensure
RETURN TO SEARCH RESULTS